These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 192114)

  • 21. Effect of pyrazinamide on nicotinamide adenine dinucleotide glycohydrolase of tuberculous host.
    Toida I
    Am Rev Respir Dis; 1973 Apr; 107(4):648-55. PubMed ID: 4348945
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metabolic behavior of Mycobacterium tuberculosis strain H37 Ra under action of rifampicin, comparison with isoniazid].
    Le Cam M; Madec Y; Bernard S
    Ann Inst Pasteur (Paris); 1971 Feb; 120(2):186-95. PubMed ID: 4396428
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a nicotinamide adenine dinucleotide glycohydrolase and an associated inhibitor in isoniazid-susceptible and -resistant Mycobacterium phlei.
    Davis WB
    Antimicrob Agents Chemother; 1980 Apr; 17(4):663-8. PubMed ID: 6249194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin B 12 synthesis by Mycobacteria. II. Isoniazid resistance & vitamin B 12 activity of Mycobacterium tuberculosis H37Rv.
    Aithal HN; Sirsi M
    Indian J Biochem; 1964 Sep; 1(3):166-7. PubMed ID: 4243420
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of isoniazid on the carbohydrate metabolism of isoniazid-susceptible and isoniazid-resistant Mycobacterium tuberculosis H37Rv.
    Murthy PS; Sirsi M; Ramakrishnan T
    Am Rev Respir Dis; 1973 Jan; 107(1):139-41. PubMed ID: 4630310
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents.
    Delaine T; Bernardes-Génisson V; Quémard A; Constant P; Meunier B; Bernadou J
    Eur J Med Chem; 2010 Oct; 45(10):4554-61. PubMed ID: 20696503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures.
    Beggs WH; Jenne JW
    Tubercle; 1969 Dec; 50(4):377-85. PubMed ID: 4983736
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical study on the host response to tuberculous infection. IV. Influences of isoniazid, streptomycin, nicotinamide, and cortisone.
    Toida I; Ando F; Yamamoto S
    Am Rev Respir Dis; 1968 Sep; 98(3):424-8. PubMed ID: 4299758
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory M
    Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An enzyme system of Mycobacterium tuberculosis that reacts specifically with isoniazid. I.
    Youatt J; Tham SH
    Am Rev Respir Dis; 1969 Jul; 100(1):25-30. PubMed ID: 4307733
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis.
    Wang L; Takayama K
    Antimicrob Agents Chemother; 1972 Dec; 2(6):438-41. PubMed ID: 4207759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
    Shkurupií VA; Kurunov IN; Arkhipov SA
    Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
    Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
    Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
    Paramasivan CN; Herbert D; Prabhakar R
    Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.
    Dickinson JM; Mitchison DA
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):367-71. PubMed ID: 6784622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of pH of the medium and other factors on the selection of isoniazid-resistant forms of M. tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1975; (9):68-71. PubMed ID: 6956
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of isoniazid on nicotinamide nucleotide levels in Mycobacterium bovis, strain BCG.
    Winder F; Collins P
    Am Rev Respir Dis; 1968 Apr; 97(4):719-20. PubMed ID: 4384559
    [No Abstract]   [Full Text] [Related]  

  • 38. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
    Karakousis PC; Williams EP; Bishai WR
    J Antimicrob Chemother; 2008 Feb; 61(2):323-31. PubMed ID: 18156607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the endogenous metabolism of mycobacteria. 3. On the influence of isonicotinic acid hydrazide on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H
    Z Naturforsch B; 1968 Jul; 23(7):982-9. PubMed ID: 4387665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.